Status:
UNKNOWN
Artificial Intelligence-assisted Common Bile Duct Stent Selection in Endoscopic Retrograde Cholangiopancreatography
Lead Sponsor:
Shandong University
Conditions:
Stenosis of Bile Duct
Endoscopic Retrograde Cholangiopancreatography
Eligibility:
All Genders
18+ years
Brief Summary
Common bile duct stenosis is an important indication for endoscopic retrograde cholangiopancreatography(ERCP). Appropriate selection of bile duct stent size is not only conducive to successful stent i...
Detailed Description
Endoscopic Retrograde Cholangiopancreatography (ERCP) is an operation with high risk. Common bile duct stone and stenosis are important indications. The quality control of ERCP is the key to improve i...
Eligibility Criteria
Inclusion
- Patients older than 18 years old who underwent ERCP
Exclusion
- failed cholangiopancreatography caused by failed intubation, gastric retention, duodenal disease and so on
- patients proved no stenosis in common bile duct
- poor cholangiograms due to the lack of contrast agent or insufficient filling of contrast agent (cholangiograms without the completed CBD or thumbnails)
Key Trial Info
Start Date :
April 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05321472
Start Date
April 20 2022
End Date
April 1 2023
Last Update
July 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gastroenterology,QiLu Hospital,Shandong University
Jinan, Shandong, China, 250012